Profile picture

Doctor Kristina Kopeva

Cardiology Research Institute, Tomsk NRMC, Tomsk (Russian Federation)
Follow
Logo ESC

Contributor content

Pharmacogenetics of therapy effectiveness for anthracycline-induced cardiotoxicity
Presentation
Pharmacogenetics of therapy effectiveness for anthracycline-induced cardiotoxicity
Read more
Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction
Presentation
Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction
Read more
Prognostic value of soluble ST2 biomarker in heart failure patients with obstructive sleep apnea syndrome
Presentation
Prognostic value of soluble ST2 biomarker in heart failure patients with obstructive sleep apnea syndrome
Read more
Anthracycline-Induced Cardiotoxicity: predictors for risk assessment in women without cardiovascular diseases
Presentation
Anthracycline-Induced Cardiotoxicity: predictors for risk assessment in women without cardiovascular diseases
Read more
Prognostic role of ST2 in heart failure patients with carbohydrate metabolism disorders
Presentation
Prognostic role of ST2 in heart failure patients with carbohydrate metabolism disorders
Read more
Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction
Presentation
Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction
Read more

ESC 365 is supported by

novartis Explore sponsored resources